Clover Health Files 8-K for Unspecified Event
Ticker: CLOV · Form: 8-K · Filed: Sep 30, 2024 · CIK: 1801170
| Field | Detail |
|---|---|
| Company | Clover Health Investments, Corp. /De (CLOV) |
| Form Type | 8-K |
| Filed Date | Sep 30, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, sec-filing
Related Tickers: CLOV
TL;DR
CLOV filed an 8-K for an 'Other Event' - need more info.
AI Summary
Clover Health Investments, Corp. (CLOV) filed an 8-K on September 26, 2024, reporting an "Other Event." The filing does not provide specific details about the event itself, but it is a standard disclosure required by the SEC for significant corporate occurrences. The company is incorporated in Delaware and its principal executive offices are located in Franklin, Tennessee.
Why It Matters
This filing indicates a material event has occurred for Clover Health, requiring public disclosure. Investors should look for further information to understand the nature and impact of this event.
Risk Assessment
Risk Level: medium — The lack of detail in the 8-K filing regarding the 'Other Event' creates uncertainty, which can be a risk for investors.
Key Numbers
- 001-39252 — Commission File Number (SEC identifier for Clover Health)
- 98-1515192 — IRS Employer Identification No. (Tax identification for Clover Health)
Key Players & Entities
- CLOVER HEALTH INVESTMENTS, CORP. (company) — Registrant
- CLOV (company) — Ticker Symbol
- September 26, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Franklin, Tennessee (location) — Address of Principal Executive Offices
FAQ
What specific event is being reported in this 8-K filing?
The filing is categorized under 'Other Events' and does not specify the exact nature of the event.
When was the earliest event reported in this filing?
The earliest event reported was on September 26, 2024.
What is Clover Health's state of incorporation?
Clover Health Investments, Corp. is incorporated in Delaware.
Where are Clover Health's principal executive offices located?
The principal executive offices are located at 3401 Mallory Lane, Suite 210, Franklin, Tennessee 37067.
What is the SEC file number for Clover Health Investments, Corp.?
The SEC file number is 001-39252.
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-09-30 16:05:55
Key Financial Figures
- $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market
Filing Documents
- clov-20240926.htm (8-K) — 25KB
- 0001801170-24-000195.txt ( ) — 148KB
- clov-20240926.xsd (EX-101.SCH) — 2KB
- clov-20240926_lab.xml (EX-101.LAB) — 22KB
- clov-20240926_pre.xml (EX-101.PRE) — 13KB
- clov-20240926_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. By letter dated September 26, 2024 (the "Notice"), the Staff of the Securities and Exchange Commission's (the "SEC") Division of Enforcement notified Clover Health Investments, Corp. (the "Company") that the SEC had concluded its investigation of the Company commenced in February 2021 (the "Investigation"), and based on the information that the SEC had as of the date of the Notice, the Staff did not intend to recommend an enforcement action by the SEC against the Company relating to the Investigation. The Notice was provided under the guidelines set forth in the final paragraph of Securities Act Release No. 5310. The Investigation was previously disclosed by the Company in its periodic reports under the Securities Exchange Act of 1934, as amended. Additional information regarding the Investigation can be found in the Company's prior filings, including the Company's Form 10-Q for the quarterly period ended June 30, 2024, filed with the SEC on August 8, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Clover Health Investments, Corp. Date: September 30, 2024 By: /s/ Karen M. Soares Name: Karen M. Soares Title: General Counsel and Corporate Secretary